This issue of the CAPS Newsletter discusses the following topics:
- X-DEA Prescription Requirements
- Prescriptions Written by a Nurse Practitioner (NP) or Physician Assistant (PA)
- Insulin Part B vs. Part D Billing
- NDC Number does NOT mean a Product is "FDA Approved"
- PBM Processing Exclusion for Non-FDA Approved Drugs
- “Use as Directed”, “As Directed”, “Per Sliding Scale” Directions
- Prescription Origin Codes
- DAW Codes (According to CMS.gov)
- OIG/SAM Monthly Exclusion Checks
- CAPS Department Contact Information